Back

Additional role of myocardial work in prognostic stratification of patients with severe aortic regurgitation

11 December 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Integrative imaging in structural interventions: valves, devices, and outcomes Valvular Heart Disease EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Luca Corda

Polyclinic Santa Maria alle Scotte, Siena (Italy)

6 More presentations in this session

Presentation thumbnail
Healing dynamics, residual flow and WATCHMAN FLX Pro device integrity after concomitant PFA and LAAC: insights from serial CT and micro-CT imaging in a canine model
Doctor W. Jaber (Cleveland, US)
Abstract Slides
Presentation thumbnail
Real-world spatial distribution of peri-device leaks on cardiac CT after WATCHMAN implantation
Professor W. Jaber (Cleveland, US)
Abstract Slides
Presentation thumbnail
Comparison of tricuspid valve regurgitation severity between the American Society of Echocardiography and the Cardiac Magnetic Resonance criteria in adults with congenital heart disease.
Associate Professor T. Tangcharoen (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Uncovering apical sparing with CTt-derived extracellular volume: regional mapping of myocardial fibrosis in aortic stenosis
Doctor A. Lobo (Vila Nova de Gaia, PT)
Abstract Slides
Presentation thumbnail
Prognostic impact of valvular calcification versus vascular calcification in patients with severe aortic stenosis
Doctor M. Hein (Bad Krozingen, DE)
Abstract Slides

Access the full session

Session thumbnail
Integrative imaging in structural interventions: valves, devices, and outcomes

The Event

Event poster

EACVI 2025

11 December - 13 December 2025
You may be interested in
thumbnail
Congress Presentation
Aortic valve disease: when and how to integrate CT for optimal planning
thumbnail
Congress Presentation
When to use cardiac magnetic resonance in aortic stenosis
thumbnail
Congress Presentation
How to use CT to guide treatment in patients with heart valve disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources